Johannes H.A.M. Kaanders

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

W. Joost Lesterhuis, Cornelis J.A. Punt, Stanleyson V. Hato et al. · Journal of Clinical Investigation · 2011 · 341 citations · Full text

Immunology, Immunoediting, Immunotherapeutics +18

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers

Timo M. Deist, Frank J. W. M. Dankers, Gilmer Valdés et al. · Medical Physics · 2018 · 296 citations · Full text

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Amanda Eustace, Navin Mani, Paul N. Span et al. · Clinical Cancer Research · 2013 · 252 citations · Full text

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

Geert O. Janssens, Saskia E. Rademakers, Chris H.J. Terhaard et al. · Journal of Clinical Oncology · 2012 · 251 citations · Full text

Comparison of Five Segmentation Tools for 18F-Fluoro-Deoxy-Glucose–Positron Emission Tomography–Based Target Volume Definition in Head and Neck Cancer

Dominic A.X. Schinagl, Wouter V. Vogel, Aswin L. Hoffmann et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 212 citations

Positron Emission Tomography, Target Volume Definition, Neck Cancer +14